✦ LIBER ✦

The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women

✍ Scribed by M. J. Bolland; R. W. Ames; A. M. Horne; B. J. Orr-Walker; G. D. Gamble; I. R. Reid

Book ID: 105864034
Publisher: Springer-Verlag
Year: 2006
Tongue: English
Weight: 193 KB
Volume: 18
Category: Article
ISSN: 0937-941X
DOI: 10.1007/s00198-006-0259-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of 1-year treatment with iprifla

Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass

✍ M. Valente; L. Bufalino; G. N. Castiglione; R. D'Angelo; A. Mancuso; P. Galoppi; 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 368 KB

Effect of 3-year treatment with ipriflav

Effect of 3-year treatment with ipriflavone on peripheral bone mass in postmenopausal women

✍ M Passeri 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 143 KB

A 4-year follow-up study of the effects

A 4-year follow-up study of the effects of calcium supplementation on bone density in elderly postmenopausal women

✍ A. Devine; I. M. Dick; S. J. Heal; R. A. Criddle; R. L. Prince 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 647 KB

Five Years of Treatment with Risedronate

Five Years of Treatment with Risedronate and its Effects on Bone Safety in Women with Postmenopausal Osteoporosis

✍ L.-G. Ste-Marie; E. Sod; T. Johnson; A. Chines 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 135 KB

Effect of parathyroidectomy for primary

Effect of parathyroidectomy for primary hyperparathyroidism on bone mineral density in postmenopausal women

✍ Professor A. Sitges-Serra; L. García; R. Prieto; M. J. Peña; X. Nogués; J. J. Sa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

Odanacatib in the treatment of postmenop

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect

✍ John A Eisman; Henry G Bone; David J Hosking; Michael R McClung; Ian R Reid; Ren 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 211 KB 👁 2 views

## Abstract The selective cathepsin K inhibitor odanacatib (ODN) progressively increased bone mineral density (BMD) and decreased bone‐resorption markers during 2 years of treatment in postmenopausal women with low BMD. A 1‐year extension study further assessed ODN efficacy and safety and the effec